Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 May 24

PMID 32443539

Citations 7

Authors

Asad Mehmood Raja

Ester Ciociola

Imran Nazir Ahmad

Faisal Saud Dar

Syed Muhammad Saqlan Naqvi

Muhammad Moaeen-Ud-Din

Ghazala Kaukab Raja

Stefano Romeo

Rosellina Margherita Mancina

Affiliations

Soon will be listed here.

Abstract

Chronic liver disease, with viral or non-viral etiology, is endemic in many countries and is a growing burden in Asia. Among the Asian countries, Pakistan has the highest prevalence of chronic liver disease. Despite this, the genetic susceptibility to chronic liver disease in this country has not been investigated. We performed a comprehensive analysis of the most robustly associated common genetic variants influencing chronic liver disease in a cohort of individuals from Pakistan. A total of 587 subjects with chronic liver disease and 68 healthy control individuals were genotyped for the rs7261356, rs641738, rs1260326, rs738409, rs58542926 and rs4841132 variants. The variants distribution between case and control group and their association with chronic liver disease were tested by chi-square and binary logistic analysis, respectively. We report for the first time that variant results in a 50% reduced risk for chronic liver disease; while and variants increase this risk by more than 35% in Pakistani individuals. Our genetic analysis extends the protective role of the variant against chronic liver disease and disease risk conferred by the ; and variants in the Pakistani population.

Citing Articles

Financial burden and social implications of chronic liver disease in a patient population group in Pakistan.

Salim A, Farooq M, Saleem S, Malik K Pak J Med Sci. 2024; 40(7):1503-1508.

PMID: 39092038 PMC: 11255803. DOI: 10.12669/pjms.40.7.7976.

Genome-wide association studies of coffee intake in UK/US participants of European ancestry uncover cohort-specific genetic associations.

Thorpe H, Fontanillas P, Pham B, Meredith J, Jennings M, Courchesne-Krak N Neuropsychopharmacology. 2024; 49(10):1609-1618.

PMID: 38858598 PMC: 11319477. DOI: 10.1038/s41386-024-01870-x.

Platelet Count to Prothrombin Time: A Noninvasive Predictor of Esophageal Varices in Patients With Chronic Liver Disease.

Rizvi S, Wallam M, Siddiqui A, Haqqi S, Farrukh Z, Niaz S Cureus. 2024; 16(5):e59627.

PMID: 38832148 PMC: 11145925. DOI: 10.7759/cureus.59627.

Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.

Moore M, Wang X, Kennelly J, Shi H, Ishino Y, Kano K Hepatology. 2024; 81(2):576-590.

PMID: 38776184 PMC: 11822724. DOI: 10.1097/HEP.0000000000000933.

Prevalence of rs1260326 Variant in Subjects with Obesity Associated NAFLD and T2DM: A Case-Control Study in South Punjab, Pakistan.

Nisar T, Arshad K, Abbas Z, Khan M, Safdar S, Shaikh R J Obes. 2023; 2023:6661858.

PMID: 37829557 PMC: 10567336. DOI: 10.1155/2023/6661858.

References

Harada R, Kimura M, Sato Y, Taniguchi T, Tomonari T, Tanaka T . APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism. BMC Gastroenterol. 2018; 18(1):24. PMC: 5791310. DOI: 10.1186/s12876-018-0747-5. View

Dongiovanni P, Petta S, Maglio C, Fracanzani A, Pipitone R, Mozzi E . Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology. 2014; 61(2):506-14. DOI: 10.1002/hep.27490. View

Rinella M . Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015; 313(22):2263-73. DOI: 10.1001/jama.2015.5370. View

Mahdessian H, Taxiarchis A, Popov S, Silveira A, Franco-Cereceda A, Hamsten A . TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content. Proc Natl Acad Sci U S A. 2014; 111(24):8913-8. PMC: 4066487. DOI: 10.1073/pnas.1323785111. View

Ma Y, Belyaeva O, Brown P, Fujita K, Valles K, Karki S . 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease. Hepatology. 2018; 69(4):1504-1519. PMC: 6438737. DOI: 10.1002/hep.30350. View

Kozlitina J, Smagris E, Stender S, Nordestgaard B, Zhou H, Tybjaerg-Hansen A . Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014; 46(4):352-6. PMC: 3969786. DOI: 10.1038/ng.2901. View

Hajarizadeh B, Grebely J, Dore G . Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013; 10(9):553-62. DOI: 10.1038/nrgastro.2013.107. View

Li Y, Xing C, Tian Z, Ku H . Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. BMC Med Genet. 2012; 13:113. PMC: 3523076. DOI: 10.1186/1471-2350-13-113. View

Kozlitina J, Stender S, Hobbs H, Cohen J . HSD17B13 and Chronic Liver Disease in Blacks and Hispanics. N Engl J Med. 2018; 379(19):1876-1877. DOI: 10.1056/NEJMc1804027. View

10.

Mancina R, Matikainen N, Maglio C, Soderlund S, Lundbom N, Hakkarainen A . Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant. J Clin Endocrinol Metab. 2015; 100(5):E821-5. DOI: 10.1210/jc.2014-4464. View

11.

Stender S, Smagris E, Lauridsen B, Kofoed K, Nordestgaard B, Tybjaerg-Hansen A . Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride. Hepatology. 2017; 67(6):2182-2195. PMC: 5991995. DOI: 10.1002/hep.29751. View

12.

Speliotes E, Yerges-Armstrong L, Wu J, Hernaez R, Kim L, Palmer C . Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011; 7(3):e1001324. PMC: 3053321. DOI: 10.1371/journal.pgen.1001324. View

13.

Holmen O, Zhang H, Fan Y, Hovelson D, Schmidt E, Zhou W . Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat Genet. 2014; 46(4):345-51. PMC: 4169222. DOI: 10.1038/ng.2926. View

14.

Sookoian S, Pirola C . Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011; 53(6):1883-94. DOI: 10.1002/hep.24283. View

15.

Pingitore P, Pirazzi C, Mancina R, Motta B, Indiveri C, Pujia A . Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. Biochim Biophys Acta. 2013; 1841(4):574-80. DOI: 10.1016/j.bbalip.2013.12.006. View

16.

Pirazzi C, Adiels M, Burza M, Mancina R, Levin M, Stahlman M . Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J Hepatol. 2012; 57(6):1276-82. DOI: 10.1016/j.jhep.2012.07.030. View

17.

Bruschi F, Claudel T, Tardelli M, Caligiuri A, Stulnig T, Marra F . The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells. Hepatology. 2017; 65(6):1875-1890. DOI: 10.1002/hep.29041. View

18.

Mancina R, Dongiovanni P, Petta S, Pingitore P, Meroni M, Rametta R . The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. Gastroenterology. 2016; 150(5):1219-1230.e6. PMC: 4844071. DOI: 10.1053/j.gastro.2016.01.032. View

19.

Prill S, Caddeo A, Baselli G, Jamialahmadi O, Dongiovanni P, Rametta R . The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Sci Rep. 2019; 9(1):11585. PMC: 6690969. DOI: 10.1038/s41598-019-47737-w. View

20.

Kitamoto T, Kitamoto A, Yoneda M, Hyogo H, Ochi H, Nakamura T . Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013; 132(7):783-92. DOI: 10.1007/s00439-013-1294-3. View